Synonyms:
Status: Phase 2
Entry Type: Protein
Molecule Category: UNKNOWN
UNII: K3D9A0ICQ3

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor ligand superfamily member 13B inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lupus Erythematosus, Systemic 2 D008180 ClinicalTrials
Multiple Sclerosis 2 D009103 ClinicalTrials
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Optic Neuritis 2 D009902 ClinicalTrials
Glomerulonephritis, IGA 2 D005922 ClinicalTrials
Lupus Nephritis 2 D008181 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 845264-92-8
ChEMBL CHEMBL1742986
FDA SRS K3D9A0ICQ3
Guide to Pharmacology 9517